Evidence map›Paper›PMID 31687608›Full record

ArticleHeliyon2019

Masoomeh Shafiei, Farzaneh Afzali, Ali Asghar Karkhane, S Mehdi Ebrahimi, Kamahldin Haghbeen, Saeed Aminzadeh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Genome sequence ofMicrobiology resource announcements · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Characterization of a Novel FeInternational journal of molecular sciences · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Masoomeh ShafieiBioprocess Engineering Group, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Iran.
Farzaneh AfzaliInstitute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Iran.
Ali Asghar KarkhaneBioprocess Engineering Group, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Iran.
S Mehdi EbrahimiDepartment of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modarres University, Iran.
Kamahldin HaghbeenInstitute of Agricultural Biotechnology, National Institute of Genetic Engineering and Biotechnology, Iran.
Saeed AminzadehBioprocess Engineering Group, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Iran.
National Institute of Genetic Engineering and Biotechnology · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laccase (EC 1.10.3.2; benzenediol; oxygen oxidoreductases) is a multi-copper oxidase that catalyzes the oxidation of phenols, polyphenols, aromatic amines, and different non-phenolic substrates with concomitant reduction of O

Indexed as

BacteriaBacterial geneticsBiotechnologyCloningCohnella sp. A01Heterologous expressionLaccaseMolecular biologyThermostable

Identifiers

PMID31687608
PMCPMC6819783
OpenAlexW2978144462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.